QFCO, Inc. of Burlingame, California is recalling White Rabbit Candy because it may be contaminated with Melamine. Product was distributed to the states of CA, GA, HI, IL, MN, NY, OR, TX, WA through wholesale distributors to retail stores.
QFCO, Inc. Recalls White Rabbit Candy Because of Possible Health Risk (September 26)
Medicare Warns of Part D Changes
Seniors are urged by officials to check their 2009 drug coverage.
WebMD Health News
“Consider” Candesartan for Diabetic Retinopathy
Despite meeting none of the primary end points in the three DIRECT studies in diabetic retinopathy, the angiotensin receptor blocker candesartan could still be considered a treatment option in certain patients with this condition, say the trial authors and accompanying editorialists.
Heartwire
Low-Dose Hormone Therapy Does Not Prevent Age-Related Facial Skin Changes
Older women’s facial wrinkles and sagging skin are not reduced by a long-term regimen of norethindrone acetate and ethinyl estradiol, according to results of a prospective multicenter clinical trial.
Reuters Health Information
Intensive Insulin Therapy in Type 1 Diabetes Lowers Long-Term Risk for Hypertension
A study shows that hyperglycemia is a risk factor for incident hypertension in type 1 diabetes and that intensive insulin therapy reduces the long-term risk for the development of hypertension.
Medscape Medical News
Acupuncture as Good as Drug at Reducing Hot Flashes in Breast Cancer Survivors
Acupuncture was as effective as venlafaxine in reducing vasomotor symptoms in breast cancer patients who are taking tamoxifen or anastrozole.
Medscape Medical News
Questions and Answers about Dioxins
The questions and answers on this page provide general information
about dioxins, a subject that can be complex and confusing. The materials presented
provide information about the Environmental Protection Agency’s (EPA) draft risk
assessment on dioxins.
FDA MedWatch - Epoetin alfa- Preliminary Safety Findings Show More Deaths In Patients Given Epoetin-alpha Versus Placebo
ROCKVILLE, Md., Sept. 26, 2008-FDA has been made aware of preliminary safety findings from a clinical trial conducted in Germany investigating the use of epoetin alfa to treat acute ischemic stroke. The clinical trial utilized doses of epoetin alfa…
Crucell’s Swiss Affiliate Berna Biotech to Cease All Animal Testing
LEIDEN, The Netherlands (September 26, 2008) - For several years the vaccine producer Berna Biotech a Swiss affiliate of Crucell N.V. has been working rigorously on the 3R program, which has a goal to Reduce, Refine and Replace all animal testing….
Myosin-Activating Agent Boosts Systolic Function, but Please Don’t Call it an “Inotrope”
It’s still in early-phase studies, but researchers hope the drug, which seems to prolong systole and enhance cardiac output without raising myocardial oxygen demand, will offer the benefits of conventional inotropic agents without their dark side.
Heartwire
Social Network
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Aug | Oct » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | |||||
Recent Entries
- Circassia Completes Patient Recruitment For Phase II Clinical Trial Of Toleromune(R) Allergy Treatment
- ImQuest Submits Investigational New Product Application To The Food And Drug Administration To Initiate HIV Therapeutic Clinical Trials With IQP-0410
- FDA Issues A Complete Response Letter For Lilly’s Olanzapine LAI For Treatment Of Schizophrenia In Adults
- Kaunitz on Women’s Health: A Safer Approach to Prescribing Menopausal Estrogen
- Sun Pharmaceutical extends tender offer for Taro
- Sun Pharmaceutical receives FDA approvals for 4 generics
- Codexis announces licensing agreement with Teva Pharmaceutical Industries
- GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
- Codexis, Teva in Licensing Agreement Final
- FDA Safety Changes: Norditropin, Rozerem, Zomig
Recent Comments
- Keine Kommentare vorhanden.
Translators
Categories
- Addictions
- Alcohol Abuse
- Complementary and Alternative Medicine
- Drug Approvals
- Drug Evaluation and Research
- Drug Shortages
- Drugs and Food Information
- Food and Nutrition Information
- Health Information
- Illegal Drugs
- Medical Devices
- Medical Devices and Radiological Health
- Pharmaceutical Industry News
- Pharmacist News
- Safety Information
- Uncategorized
Archives
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 1969
Pages
Blogroll
- Alcohol / Addiction / Illegal Drugs News From Medical News Today - Latest Alcohol / Addiction / Illegal Drugs News From Medical News Today.
- Alcohol and Alcoholism - current issue - Alcohol and Alcoholism - RSS feed of current issue
- CDRH Consumer News - Items added to the Center for Devices and Radiological Health’s Consumer website within the last month.
- Centre for Reviews and Dissemination (CRD) - CRD undertakes reviews of research about the effects of interventions used in health and social care.
- Complementary and Alternative Medicine Specialist Library - This feed highlights some of the latest resources added to the Complementary and Alternative Medicine Specialist Library.
- Drugs.com - New Drug Applications - Reports of new drug applications (or withdrawals of such applications) by pharmaceutical companies.